Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic

Healthcare provider (HCP) recommendation of the human papillomavirus (HPV) vaccination is crucial for HPV vaccination acceptance and uptake. It is unclear to what extent the disruptive effect of the COVID-19 pandemic impacted the recommendation and acceptance of HPV vaccination. HCPs practicing in T...

Full description

Bibliographic Details
Main Authors: Ikponmwosa Osaghae, Onyema Greg Chido-Amajuoyi, Sanjay Shete
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/9/1515
_version_ 1797481578159407104
author Ikponmwosa Osaghae
Onyema Greg Chido-Amajuoyi
Sanjay Shete
author_facet Ikponmwosa Osaghae
Onyema Greg Chido-Amajuoyi
Sanjay Shete
author_sort Ikponmwosa Osaghae
collection DOAJ
description Healthcare provider (HCP) recommendation of the human papillomavirus (HPV) vaccination is crucial for HPV vaccination acceptance and uptake. It is unclear to what extent the disruptive effect of the COVID-19 pandemic impacted the recommendation and acceptance of HPV vaccination. HCPs practicing in Texas were invited to complete an online survey between January and April 2021. This population-based survey examined the association between HPV vaccination recommendation by HCPs and their observed changes in HPV vaccination acceptance during the COVID-19 pandemic. Of the total 715 HCPs included in this study, 13.9% reported a decrease, 8.7% reported an increase, and 77.5% reported no change in HPV vaccination acceptance during the COVID-19 pandemic. Compared to the HCPs who never/sometimes recommend HPV vaccination, those who often/always recommend HPV vaccination were less likely to observe a decrease (12.3% vs. 22.1%) and more likely to observe an increase in HPV vaccination (9.1% vs. 6.2%), during the COVID-19 pandemic. Furthermore, those who provided recommendations often/always had 46% (odds ratio: 0.54; 95%CI: 0.30–0.96) lower odds of reporting a decrease in HPV vaccination acceptance during the COVID-19 pandemic. This study adds to prior evidence of the positive influence of provider recommendations on HPV vaccination acceptance despite the disruptive effect of the COVID-19 pandemic on cancer prevention services.
first_indexed 2024-03-09T22:16:36Z
format Article
id doaj.art-c3511c3d1019412d8a2bd4281dc21d23
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T22:16:36Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-c3511c3d1019412d8a2bd4281dc21d232023-11-23T19:22:26ZengMDPI AGVaccines2076-393X2022-09-01109151510.3390/vaccines10091515Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 PandemicIkponmwosa Osaghae0Onyema Greg Chido-Amajuoyi1Sanjay Shete2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USAHealthcare provider (HCP) recommendation of the human papillomavirus (HPV) vaccination is crucial for HPV vaccination acceptance and uptake. It is unclear to what extent the disruptive effect of the COVID-19 pandemic impacted the recommendation and acceptance of HPV vaccination. HCPs practicing in Texas were invited to complete an online survey between January and April 2021. This population-based survey examined the association between HPV vaccination recommendation by HCPs and their observed changes in HPV vaccination acceptance during the COVID-19 pandemic. Of the total 715 HCPs included in this study, 13.9% reported a decrease, 8.7% reported an increase, and 77.5% reported no change in HPV vaccination acceptance during the COVID-19 pandemic. Compared to the HCPs who never/sometimes recommend HPV vaccination, those who often/always recommend HPV vaccination were less likely to observe a decrease (12.3% vs. 22.1%) and more likely to observe an increase in HPV vaccination (9.1% vs. 6.2%), during the COVID-19 pandemic. Furthermore, those who provided recommendations often/always had 46% (odds ratio: 0.54; 95%CI: 0.30–0.96) lower odds of reporting a decrease in HPV vaccination acceptance during the COVID-19 pandemic. This study adds to prior evidence of the positive influence of provider recommendations on HPV vaccination acceptance despite the disruptive effect of the COVID-19 pandemic on cancer prevention services.https://www.mdpi.com/2076-393X/10/9/1515HPV vaccinationCOVID-19healthcare providerprovider recommendationvaccination acceptance
spellingShingle Ikponmwosa Osaghae
Onyema Greg Chido-Amajuoyi
Sanjay Shete
Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
Vaccines
HPV vaccination
COVID-19
healthcare provider
provider recommendation
vaccination acceptance
title Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
title_full Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
title_fullStr Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
title_full_unstemmed Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
title_short Healthcare Provider Recommendations and Observed Changes in HPV Vaccination Acceptance during the COVID-19 Pandemic
title_sort healthcare provider recommendations and observed changes in hpv vaccination acceptance during the covid 19 pandemic
topic HPV vaccination
COVID-19
healthcare provider
provider recommendation
vaccination acceptance
url https://www.mdpi.com/2076-393X/10/9/1515
work_keys_str_mv AT ikponmwosaosaghae healthcareproviderrecommendationsandobservedchangesinhpvvaccinationacceptanceduringthecovid19pandemic
AT onyemagregchidoamajuoyi healthcareproviderrecommendationsandobservedchangesinhpvvaccinationacceptanceduringthecovid19pandemic
AT sanjayshete healthcareproviderrecommendationsandobservedchangesinhpvvaccinationacceptanceduringthecovid19pandemic